El trabajo, desarrollado por investigadores del CTB-UPM es el primero en estudiar la conectividad funcional en familiares de Alzhéimer usando la técnica de magnetoencefalografía. Supone una nueva v...
Read morePharmaceutical company Almirall, a CataloniaBio & HealthTech member, and biotechnology firm Tyris Therapeutics have announced a new alliance to develop non-viral gene therapies to treat minority derma...
Read moreOriol Sibila lidera un proyecto para conocer, por un lado, los factores de riesgo que hacen que algunos enfermos de COVID-19 presenten una insuficiencia respiratoria grave, y por otro, los que hacen q...
Read moreProjects working towards the development of digital and MedTech solutions are on its rise. However before starting to develop these new solutions, it is essential to understand the current landscape f...
Read moreHow good are you at using your routine or research microscope in the lab or in the Andrology setting? If you cannot immediately answer the following three questions, then you are not using the microsc...
Read moreAdvances in clinical pharmacology and cancer research are fueling the rise of high potency active pharmaceutical ingredients (HPAPIs).
Read moreInvestigadores del Clínic-IDIBAPS y del CIBEREHD han participado en un estudio de fase 2 con Carbalive ™, un producto candidato para el tratamiento de pacientes con cirrosis descompensada. Los resu...
Read moreCon la voluntad de hacer más atractivas las carreras investigadoras en Europa, en el año 2005 la Comisión Europea adoptó una Carta Europea para Investigadores y un Código de Conducta para la Cont...
Read moreResearchers from the Universitat Rovira i Virgili’s research group TecnATox have optimised the website FishChoice, which helps to consume fish and seafood in a sustainable fashion and not just maxim...
Read moreThe book “Nucleic Acids Chemistry” takes the most important aspects of the methodology of oligonucleotides synthesis, that is currently expanding by the endorsement of a dozen of new medicines, su...
Read moreDermoglass becomes the first project funded by the CaixaImpulse program to be licensed to a pharmaceutical company, Laboratorios ERN. It is a new technology to tackle chronic ulcers developed by the r...
Read moreWith the participation of the Lleida researcher Reinald Pamplona
Read more